`

I-Mab Biopharma

Biotechnology

Specialities :
Biopharmaceutical
Antibody
Immuno-oncology
Biologics
Drug development

+3

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$418.0M
size-icon Size
51 - 200

Frequently Asked Questions About I-Mab Biopharma

What does I-mab biopharma do?+

I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in the U.S. in Rockville, Maryland, and in San Diego, California

What are I-mab biopharma's specialties? +

Biopharmaceutical,antibody,immuno-oncology ,biologics,drug development ,cancer,bispecific antibodies,and monoclonal antibodies

What is I-mab biopharma's industry? +

I-mab biopharma operates in the Biotechnology industry.

What is I-mab biopharma's revenue? +

I-mab biopharma's revenue is 11m - 100m

What is I-mab biopharma's company size? +

I-mab biopharma has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.